Optimization of Surgical Hand Preparation Using Sorbectol
Launched by UNIVERSIDAD COMPLUTENSE DE MADRID · Nov 12, 2024
Trial Information
Current as of July 01, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a hand-washing product called Sorbectol, which is used to prepare hands for surgery. Previous research has shown that Sorbectol is effective, and this trial aims to find out the best amount of time to apply it—ranging from 1 to 5 minutes—following specific guidelines to ensure it's done correctly.
To participate, individuals should be between the ages of 65 and 74, have healthy skin on both hands, and short fingernails. It's important that participants have not used antibacterial products for at least three days or taken antibiotics for at least ten days before the trial. Participants should expect to follow instructions on how to wash their hands using Sorbectol, and they will not be allowed to wear any jewelry on their hands. This study is currently looking for volunteers, and anyone interested should ensure they meet the eligibility requirements.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Participants with healthy skin in both hands and short fingernails.
- • No use of antibacterial agents for at least three days before the intervention.
- • Not received antibiotic treatment for at least ten days before the intervention.
- Exclusion Criteria:
- • Known systemic pathologies.
- • Wearing hand jewelry on the hands.
- • Allergy to any ingredient of which the solutions used in the clinical trial are composed.
- • Cognitive and / or motor limitation that makes it impossible to carry out instructions for hand washing.
About Universidad Complutense De Madrid
The Universidad Complutense de Madrid (UCM) is a prestigious academic institution renowned for its commitment to research and innovation in various fields, including health sciences. As a prominent sponsor of clinical trials, UCM leverages its extensive resources and expertise to advance medical knowledge and improve patient outcomes. The university fosters collaboration among researchers, clinicians, and industry partners, ensuring the highest standards of ethics and scientific rigor in its clinical research initiatives. UCM's dedication to education and research excellence positions it as a leader in the development of new therapeutic interventions and health solutions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Madrid, , Spain
Patients applied
Trial Officials
PARRA
Principal Investigator
UNIVERSIDAD COMPLUTENSE MADRID
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported